Closed · RFA-DA-10-003 · CFDA 93.279 · Discretionary

Integrating Translational Neuroscience and Adolescent Drug Abuse Treatment (R21)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

up to $200K
Award range
Closed
Status
September 1, 2009
Close date
-
Expected awards

The verdict

Integrating Translational Neuroscience and Adolescent Drug Abuse Treatment (R21) is a closed discretionary listing from National Institutes of Health that offered Up to $200,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

up to $200K
award range
Closed
application status
93.279
CFDA program
12,419
other opportunities from National Institutes of Health

Archived opportunity record

Integrating Translational Neuroscience and Ad… is closed (last close September 1, 2009). The parent program page for CFDA 93.279 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed September 1, 2009

Posted May 28 Closes Sep 1

Est. Total Funding

$1,500,000

Instrument

Grant

Description

Purpose. This FOA encourages exploratory/developmental grant applications to develop collaborations integrating developmental neuroscience and adolescent drug abuse treatment. The primary goal of this announcement is to facilitate translational research that ultimately integrates findings from research on brain development, cognition and neuroscience into the development of innovative and effective, developmentally sensitive drug abuse treatments for adolescents. The grants awarded under this program will allow investigative teams exploratory and planning resources to develop translational research proposals for subsequent R01 grant application. This may include preliminary studies, scientific workshops, specialized training in research methodologies and other collaborative activities to foster multidisciplinary and/or multi-site translational research approaches to adolescent drug abuse treatment. Mechanism of Support. This FOA will utilize the R21 grant mechanism, as The National Institute on Drug Abuse recognizes the exploratory and developmental nature of this research. Funds Available and Anticipated Number of Awards. The total amount of funding that the NIDA expects to award through this announcement is $1,500,000 for an anticipated 3-4 awards.

Wide-open applicant board · 15 Grants.gov doors

Integrating Translational Neuroscience and Ad… prints 15 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +11 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity codes span Education · Health (ED;HL). This eligibility-code string dominates the National Institutes of Health book (9,741 peers, 78% of 12,420).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses
Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Integrating Translational Neuroscience and Ad… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.279 may publish future NOFOs under the same assistance listing. Open program
  • Drug Abuse Research Programs indexes 170 Grants.gov listings in this extract. Program profile
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants